Digest Network Come funziona
Network
/
Società
CY
Non verificato

CYBIN Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VariePsichiatriaSalute

34 comunicati stampa

Guarda tutti i comunicati
13/06/2025
Medicina alternativa
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Cybin Provides Corporate Update and Highlights Positive Regulatory Signals for Psychedelic Therapeutics
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
12/06/2025
Medicina alternativa
Psichiatria
Salute
Sanità
Farmaceutica
Biotecnologia
Web e Social Network
Eventi
Cybin to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Conference
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
11/06/2025
Eventi
Biotecnologia
Psichiatria
Salute
Medicina - Varie
Cybin to Participate in the 2025 Psychedelic Science Conference
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
03/06/2025
Psichiatria
Scienza
Biotecnologia
Sanità
Medicina alternativa
Salute
Farmaceutica
Industria
Cybin Announces Additional U.S. Patent Supporting its CYB004 Program in Phase 2 Development for Generalized Anxiety Disorder
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
22/05/2025
Eventi
Web e Social Network
Psichiatria
Scienza
Biotecnologia
Sanità
Medicina alternativa
Salute
Farmaceutica
Cybin to Participate in Water Tower Research Fireside Chat on May 29, 2025
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
20/05/2025
Mercato del lavoro
Industria
Psichiatria
Scienza
Igiene alimentare
Medicina - Varie
Sanità
Salute
Farmaceutica
Cybin Applauds FDA Commissioner Dr. Martin Makary’s Call to Accelerate and Prioritize Research on Psychedelic Therapeutics
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
15/05/2025
Mercato del lavoro
Industria
Psichiatria
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Cybin Engages Thermo Fisher Scientific to Provide U.S.-Based Manufacturing for its CYB003 Program for the Adjunctive Treatment of Major Depressive Disorder
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
14/05/2025
Web e Social Network
Industria
Eventi
Medicina alternativa
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Cybin to Participate in the Alliance Global Partners Healthcare Company Showcase
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
08/05/2025
Industria
Medicina alternativa
Psichiatria
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Cybin Announces Additional U.S. Patent Supporting its CYB003 Breakthrough Therapy Program in Phase 3 Development for Major Depressive Disorder
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0
01/05/2025
Web e Social Network
Eventi
Farmaceutica
Salute
Psichiatria
Cybin to Participate at the 28th Annual Milken Institute Global Conference
Fonte
CYBIN Inc.
Emittente
Business Wire
1,00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0